Redefining Evidence Generation In Modern Clinical Trials

By Colin Weller, General Manager, Platform and Digital Solutions

The clinical research industry is currently shifting towards patient-centric approaches and utilizing digital biomarkers and endpoints to enhance the efficiency and precision of evidence generation. Medable recognizes the effectiveness of wearable technology and digital endpoints in trials for Duchenne Muscular Dystrophy, which has resulted in significant cost and time savings.

One of the major challenges in clinical trials is patient recruitment delays, which can significantly impact the overall timeline of a trial. By reducing the required number of participants, Medable's platform can help address this issue. Their platform is purpose-built for evidence generation, streamlining the process of data collection and ensuring compliance with regulations.

Medable has recently gained notable sponsors, indicating their credibility and readiness to assist anyone conducting a trial. They aim to increase the speed at which evidence is generated in the future, further improving the efficiency of the clinical trial process.